Phenotype and Function of Activated Natural Killer Cells From Patients With Prostate Cancer: Patient-Dependent Responses to Priming and IL-2 Activation
Background: Although immunotherapy has emerged as the “next generation” of cancer treatments, it has not yet been shown to be successful in the treatment of patients with prostate cancer, for whom therapeutic options remain limited to radiotherapy and androgen (hormone) deprivation therapy. Previous...
Main Authors: | Simon P. Hood, Gemma A. Foulds, Heather Imrie, Stephen Reeder, Stéphanie E. B. McArdle, Masood Khan, Alan Graham Pockley |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2018.03169/full |
Similar Items
-
Therapeutic approaches to enhance natural killer cell cytotoxicity
by: Terran D. Stenger, et al.
Published: (2024-03-01) -
Relative expression of receptors in uterine natural killer cells compared to peripheral blood natural killer cells
by: Nurul Izza Ismail
Published: (2023-03-01) -
Human immunodeficiency syndromes affecting human natural killer cell cytolytic activity
by: Daniel Denis Billadeau, et al.
Published: (2014-01-01) -
Natural Killer Cells and Cytotoxic T Cells: Complementary Partners against Microorganisms and Cancer
by: Aristo Vojdani, et al.
Published: (2024-01-01) -
Natural Born Killers: NK Cells in Cancer Therapy
by: S. Elizabeth Franks, et al.
Published: (2020-07-01)